Tweenvest Stocks

Starling Oncology, Inc. (NasdaqCM: STLN)

Health Care · Health Care Providers & Services · US

$6.30

-2.55% today · +86.3% 1Y

Starling Oncology, Inc. (NasdaqCM: STLN) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $658.89M and employs 641 people.

Over the last twelve months the share price has gained 86.3%, trading between 2.32 and 7.05.

Tweenvest scores Starling Oncology, Inc. across four factors: quality 28/100, value 43/100. Its strongest factor is value.

STLN price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$658.89M
Revenue (TTM)
$587.24M
P/E
EPS
-0.30
Dividend yield
Beta (5Y)
0.42
52-week high
$7.05
52-week low
$2.32
Avg volume (3M)
Shares outstanding
101.92M
Employees
641
Next earnings

About Starling Oncology, Inc.

Starling Oncology, Inc., formerly The Oncology Institute, is a value-based oncology company advancing cancer care in the community setting. Founded in 2007, the company offers cutting-edge, evidence-based cancer treatments, including clinical trials and transfusions, to a large patient population. It operates as an integrated oncology platform serving patients, providers, and health plans across multiple markets with a focus on delivering high-quality, patient-centered care.

ISIN
US68236X1000
Founded
2007
Listed since
Aug 4, 2026
Exchange
Nasdaq Capital Market
Currency
USD
CompanyMarket capPriceDay
UnitedHealth Group IncorporatedNYSE: UNH$355.98B$397.77+0.30%
CVS Health CorporationNYSE: CVS$118.82B$93.00+0.11%
McKesson CorporationNYSE: MCK$105.52B$905.09+3.58%
HCA Healthcare, Inc.NYSE: HCA$92.83B$428.76-0.11%
Elevance Health, Inc.NYSE: ELV$86.50B$398.87-0.93%
The Cigna GroupNYSE: CI$73.81B$279.32-0.40%
Cencora, Inc.NYSE: COR$62.60B$328.06+1.33%
Cardinal Health, Inc.NYSE: CAH$55.33B$237.92+2.39%

Browse every Health Care Providers & Services company →

Figures last refreshed Aug 18, 2026.